Physician profile
Zane Khademi
NPI 1598261018
$1,988.87
in general payments reported to CMS, 2019-2025
10 companies · $569 in 2025
The $569 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $146 · 2023: $592 · 2024: $681 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,842.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $554.75 | 2023-2025 | Hydrus Microstent |
| Abbvie INC. | $353.62 | 2023-2025 | |
| Sight Sciences, INC. | $320.64 | 2024-2025 | Omni Surgical System |
| Nova Eye, INC. | $265.18 | 2025 | |
| Genentech USA, INC. | $118.48 | 2022 | |
| Eyepoint US, INC. | $107.47 | 2023 | |
| Mallinckrodt Hospital Products INC. | $99.99 | 2023 | Acthar |
| Glaukos Corporation | $97.36 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Bausch & Lomb Americas INC. | $43.70 | 2023 | Xipere |
| Regeneron Healthcare Solutions, INC. | $27.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zane Khademi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.